Recent studies suggest that GLP-1 also mediates the metabolic effects of metformin, gut microbiota, and bariatric surgery 3,4,5,6
So this is where I think people who follow the podcast closely know there's a good balance between modalities and there's a correct place for medications
Despite their programmability, high affinity, and synthetic accessibility, the clinical translation of aptamer-based modalities is tempered by significant in vivo challenges
CrossRef Di-Folco U, Vallecorsa N, Nardone MR, Pantano AL, Tubili C
Skipping this step can lead to disappointing results or health complications that could have been easily prevented
Do you have more questions regarding the suitability of semaglutide